Mesoblast annual current ratio
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Mesoblast Current Ratio Growth & History (MESO)
Mesoblast's current ratio was 2.43 for fiscal 2026.
View full Mesoblast company overviewMesoblast annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-06-30 | 2.43 | 0.44 | +22.28% |
| 2025 | 2025-06-30 | 1.99 | 0.81 | +68.68% |
| 2024 | 2024-06-30 | 1.18 | −0.76 | −39.31% |
| 2023 | 2023-06-30 | 1.95 | 0.59 | +43.08% |
| 2022 | 2022-06-30 | 1.36 | −0.21 | −13.54% |
| 2021 | 2021-06-30 | 1.57 | 0.06 | +3.80% |
| 2020 | 2020-06-30 | 1.51 | 0.10 | +7.41% |
| 2019 | 2019-06-30 | 1.41 | −2.80 | −66.51% |
| 2018 | 2018-06-30 | 4.21 | 2.48 | +142.75% |
| 2017 | 2017-06-30 | 1.73 | — | — |
Mesoblast quarterly current ratio
Q4.17
Q4.18
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q3.21
Q4.21
Q1.22
Q3.22
Q4.22
Q1.23
Q3.23
Q4.23
Q4.24
Q2.25
Q4.25
Q2.26
Q4.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q4 2026 | 2026-06-30 | 2.43 | 0.44 | +22.28% |
| Q2 2026 | 2025-12-31 | 1.58 | 0.62 | +65.07% |
| Q4 2025 | 2025-06-30 | 1.99 | 0.81 | +68.68% |
| Q2 2025 | 2024-12-31 | 0.96 | — | — |
| Q4 2024 | 2024-06-30 | 1.18 | −0.76 | −39.31% |
| Q4 2023 | 2023-06-30 | 1.95 | 0.59 | +43.08% |
| Q3 2023 | 2023-03-31 | 1.14 | −0.55 | −32.61% |
| Q1 2023 | 2022-09-30 | 1.90 | 0.55 | +40.20% |
| Q4 2022 | 2022-06-30 | 1.36 | −0.21 | −13.54% |
| Q3 2022 | 2022-03-31 | 1.69 | −0.03 | −1.97% |
| Q1 2022 | 2021-09-30 | 1.36 | 0.04 | +2.95% |
| Q4 2021 | 2021-06-30 | 1.57 | 0.06 | +3.80% |
| Q3 2021 | 2021-03-31 | 1.72 | 0.82 | +90.38% |
| Q1 2021 | 2020-09-30 | 1.32 | 0.46 | +52.66% |
| Q4 2020 | 2020-06-30 | 1.51 | 0.10 | +7.41% |
| Q3 2020 | 2020-03-31 | 0.90 | −1.02 | −52.92% |
| Q2 2020 | 2019-12-31 | 1.21 | −1.68 | −58.09% |
| Q1 2020 | 2019-09-30 | 0.86 | — | — |
| Q4 2019 | 2019-06-30 | 1.41 | −2.80 | −66.51% |
| Q3 2019 | 2019-03-31 | 1.92 | — | — |
| Q2 2019 | 2018-12-31 | 2.89 | — | — |
| Q4 2018 | 2018-06-30 | 4.21 | 2.48 | +142.75% |
| Q4 2017 | 2017-06-30 | 1.73 | — | — |
Mesoblast current ratio trends
Over the last five fiscal years, Mesoblast's current ratio increased from 1.57 to 2.43, a change of 0.86. The latest reported quarter, Q4 2026, shows 2.43.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Mesoblast source filings ↗